Gastroesophageal reflux disease and Barrett's esophagus

Medical Clinics of North America

Volumn 84, Issue 5, 2000, Pages 1137-1161

  Katzka, David A ^b   Rustgi, Anil K ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNAGEL; ALUMINUM HYDROXIDE; ALUMINUM MAGNESIUM HYDROXIDE; ANTACID AGENT; GAVISCON; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; MYLANTA; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; TUMS;

BARRETT ESOPHAGUS; CANCER RISK; CANCER SCREENING; DIFFERENTIAL DIAGNOSIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL RADIOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIFESTYLE; PATHOPHYSIOLOGY; PH MEASUREMENT; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REVIEW; STOMACH FUNDOPLICATION; SURGICAL TECHNIQUE; SYMPTOMATOLOGY;

EID: 0033833924     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70280-7     Document Type: Article

References (75)

1. Barrett's esophagus in African Americans of an inner city population
2. Outcome of laparoscopic Nissen fundoplication in patients with disordered preoperative peristalsis
3. Esophageal dysmotility is not associated with poor outcome after laparoscopic Nissen fundoplication
4. Involvement of cholecystokinin A receptors in transient lower esophageal sphincter relaxations triggered by gastric distension
5. Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans
6. Role of the diaphragm in the genesis of lower esophageal sphincter pressure in the cat
7. Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: Alcohol, tobacco and socieconomic factors
8. Prevalence of columnar-lined (Barrett's) esophagus: Comparison of population based clinical and autopsy findings
9. The rumination syndrome: Clinical features rather than manometric diagnosis
10. Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: Clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation
11. Nissen fundoplication for gastroesophageal reflux disease: Evaluation of primary repair in 100 consecutive patients
12. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects
13. Omeprazole v ranitadine for prevention of relapse in reflux esophagitis: A controlled double blind trial of their efficacy and safety
14. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain
15. Relationships between the acidity and osmolality of popular beverages and reported postprandial heartburn
16. Response of canine lower esophageal sphincter to gastric distension
17. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid
18. Efficacy and tolerability of famotidine in preventing heartburn and related symptoms of upper gastrointestinal discomfort
19. Value of Nissen fundoplication in patients with gastro-esophageal reflux disease judged by long term symptom control
20. Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesophageal reflux
21. Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients
22. Esophageal acid sensitivity in Barrett's esophagus
23. Effect of fundoplication on transient lower oesophageal sphincter relaxation and gas reflux
24. Elevation of the head of the bed, bethanechol, and antacid foam tablets on gastroesophageal reflux
25. Omeprazole failure in a patient with gastroesophageal reflux disease
26. Esophageal peristaltic dysfunction in peptic esophagitis
27. Ambulatory esophageal and hypopharyngeal monitoring pH monitoring in patients with hoarseness
28. Motility abnormalities in gastroesophageal reflux disease
29. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus
30. Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma
31. Influence of spontaneous sleep positions on night time recumbent reflux in patients with gastroesophageal reflux disease
32. Diagnostic inconsistencies in Barrett's esophagus. Department of Veteran Affairs Reflux Study Group
33. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa
34. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): A clinical investigation of 225 patients using ambulatory 24-hour pH monitoring of laryngeal injury
35. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis
36. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
37. Association between body mass and adenocarcinoma of the esophagus and gastric cardia
38. Evidence for diminished visceral pain with aging: Studies using graded intraesophageal ballon distention
39. Activation of the GABA(B) receptor inhibits transient lower esophageal sphincter relaxations in dogs
40. Persistent acid secretion during omeprazole therapy: A study of gastric acid profiles in patients demonstrating failure of omeprazole therapy
41. Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12)
42. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis
43. Esophageal motility before and after laparoscopic Nissen fundoplication
44. Reliability of 24-hour home esophageal monitoring in diagnosis of gastroesophageal disease
45. Gastric emptying in patients with gastroesophageal reflux
46. Ranitadine versus cimetidine in the healing of erosive esophagitis
47. Esophageal involvement in the Zollinger-Ellison syndrome
48. Transient lower esophageal sphincter relaxation
49. Sphincteric action of the diaphragm during a relaxed lower esophageal sphincter in humans
50. Esophageal manometry and pH recording does not predict the bad results of Nissen fundoplication
51. Evidence of gender differences in esophageal pain threshold
52. The rumination syndrome: Clinical features rather than manometric diagnosis
53. Differentiation and proliferation in Barrett's esophagus and the effects on acid suppression
54. Photodynamic therapy for Barrett's esophagus: Clinical update
55. Ranitadine controls nocturnal gastric acid breakthrough on ompetrazole: A controlled study in normal subjects
56. Laparoscopic Nissen fundoplication: Where do we stand?
57. Observer variation in the diagnosis of dysplasia in Barrett's esophagus
58. Low dose famotidine and ranitidine as single postprandial doses: A three-period placebo-controlled comparative trial
59. Familial aggregation of gastroesophageal reflux in patients with Barret's esophagus and esophageal adenocarcinoma
60. Does esophageal motor function improve with time after successful antireflux surgery? Results of a prospective, randomized clinical study
61. Barrett esophagus after chemotherapy with cydophosphamide, methotrexate, and 5-fluorouracil (CMF): An iatrogenic injury
62. Optimal dose of oral omeprazole for maximal 24 hour decrease in intragastric acidity
63. Efficacy of twice daily doses of 40 or 20 milligrams famotidine or 150 milligrams ranitadine for treatment of patients with moderate to severe erosive esophagitis
64. Determinants of gastroesophageal junction incompetence: Hiatal hernia, lower esophageal sphincter, or both
65. Barrett's esophagus in children and young adults: Frequent association with mental retardation
66. Gastroesophageal reflux among severely retarded children
67. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans
68. The effects of antireflux therapy on pulmonary function in patients with severe gastroesophageal reflux disease
69. Barrett's epithelium complicating lye ingestion with sparing of the distal esophagus
70. Impact of endoscopic biopsy surveillance of Barrett's esophagus on pathological stage and clinical outcome of Barrett's carcinoma
71. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease
72. A comparison of five maintenance therapies for reflux esophagitis
73. Reproducibility and physiological characteristics of 24-hour ambulatory esophageal manometry/pH-metry
74. Ambulatory 24-hour esophageal pH monitoring: Reproducibility and variability of pH parameters
75. Omeprazole administration as a test for gastroesophageal reflux